148 related articles for article (PubMed ID: 11257336)
1. Influenza vaccines: a review and rationale for use in developed and underdeveloped countries.
Poland GA; Rottinghaus ST; Jacobson RM
Vaccine; 2001 Mar; 19(17-19):2216-20. PubMed ID: 11257336
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.
Ott JJ; Klein Breteler J; Tam JS; Hutubessy RC; Jit M; de Boer MR
Hum Vaccin Immunother; 2013 Jul; 9(7):1500-11. PubMed ID: 23732900
[TBL] [Abstract][Full Text] [Related]
3. WHO guide on the economic evaluation of influenza vaccination.
Newall AT; Chaiyakunapruk N; Lambach P; Hutubessy RCW
Influenza Other Respir Viruses; 2018 Mar; 12(2):211-219. PubMed ID: 29024434
[TBL] [Abstract][Full Text] [Related]
4. Influenza cost and cost-effectiveness studies globally--a review.
Peasah SK; Azziz-Baumgartner E; Breese J; Meltzer MI; Widdowson MA
Vaccine; 2013 Nov; 31(46):5339-48. PubMed ID: 24055351
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
Imai C; Toizumi M; Hall L; Lambert S; Halton K; Merollini K
PLoS One; 2018; 13(6):e0198685. PubMed ID: 29879206
[TBL] [Abstract][Full Text] [Related]
6. Costs and effectiveness of influenza vaccination: a systematic review.
D'Angiolella LS; Lafranconi A; Cortesi PA; Rota S; Cesana G; Mantovani LG
Ann Ist Super Sanita; 2018; 54(1):49-57. PubMed ID: 29616674
[TBL] [Abstract][Full Text] [Related]
7. Vaccinating healthcare workers against influenza to protect the vulnerable--is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation.
Burls A; Jordan R; Barton P; Olowokure B; Wake B; Albon E; Hawker J
Vaccine; 2006 May; 24(19):4212-21. PubMed ID: 16546308
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.
Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K
JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of childhood influenza vaccination in Europe: results from a systematic review.
Boccalini S; Bechini A; Moscadelli A; Paoli S; Schirripa A; Bonanni P
Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):911-922. PubMed ID: 33930994
[No Abstract] [Full Text] [Related]
11. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines.
Nichol KL
Vaccine; 2003 May; 21(16):1769-75. PubMed ID: 12686092
[TBL] [Abstract][Full Text] [Related]
12. Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria.
Gasparini R; Lucioni C; Lai P; Maggioni P; Sticchi L; Durando P; Morelli P; Comino I; Calderisi S; Crovari P
Vaccine; 2002 Dec; 20 Suppl 5():B50-4. PubMed ID: 12477420
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.
Raviotta JM; Smith KJ; DePasse J; Brown ST; Shim E; Nowalk MP; Wateska A; France GS; Zimmerman RK
Vaccine; 2017 Oct; 35(42):5708-5713. PubMed ID: 28890196
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of the health economic consequences of quadrivalent influenza vaccination.
de Boer PT; van Maanen BM; Damm O; Ultsch B; Dolk FCK; Crépey P; Pitman R; Wilschut JC; Postma MJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):249-265. PubMed ID: 28613092
[TBL] [Abstract][Full Text] [Related]
15. Economic value of influenza vaccination.
de Waure C; Veneziano MA; Cadeddu C; Capizzi S; Specchia ML; Capri S; Ricciardi W
Hum Vaccin Immunother; 2012 Jan; 8(1):119-29. PubMed ID: 22251999
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Yang MC; Tan EC; Su JJ
Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.
Nichol KL
Vaccine; 2011 Oct; 29(43):7554-8. PubMed ID: 21820477
[TBL] [Abstract][Full Text] [Related]
18. Vaccines for seasonal and pandemic influenza.
Nichol KL; Treanor JJ
J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries.
Lall D; Cason E; Pasquel FJ; Ali MK; Narayan KM
COPD; 2016; 13(1):93-9. PubMed ID: 26418892
[TBL] [Abstract][Full Text] [Related]
20. [Economic and Health impact of influenza vaccination with adjuvant MF59 in population over 64 years in Spain].
Pérez-Rubio A; Eiros JM
Rev Esp Quimioter; 2018 Feb; 31(1):43-52. PubMed ID: 29355006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
